InvestorsObserver
×
News Home

Where Does Tenaya Therapeutics Inc (TNYA) Stock Fall in the Biotechnology Field After It Is Down -3.53% This Week?

Thursday, February 16, 2023 03:36 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Tenaya Therapeutics Inc (TNYA) Stock Fall in the Biotechnology Field After It Is Down -3.53% This Week?

Tenaya Therapeutics Inc (TNYA) is near the middle in its industry group according to InvestorsObserver. TNYA gets an overall rating of 42. That means it scores higher than 42 percent of stocks. Tenaya Therapeutics Inc gets a 45 rank in the Biotechnology industry. Biotechnology is number 51 out of 148 industries.

Overall Score - 42
TNYA has an Overall Score of 42. Find out what this means to you and get the rest of the rankings on TNYA!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Tenaya Therapeutics Inc Stock Today?

Tenaya Therapeutics Inc (TNYA) stock is trading at $2.73 as of 3:33 PM on Thursday, Feb 16, a drop of -$0.33, or -10.78% from the previous closing price of $3.06. The stock has traded between $2.72 and $3.11 so far today. Volume today is low. So far 248,717 shares have traded compared to average volume of 368,643 shares. Click Here to get the full Stock Report for Tenaya Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App